TumorGen
San Diego
About TumorGen
TumorGen is developing the tools necessary to help create new drugs that specifically target metastases. Its technology is a versatile microfluidic platform that is pioneering drug discovery against circulating tumor cell clusters, the drivers of metastasis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $390.0K
- Last round: Grant (Aug 2021)
- Website: tumorgen.net
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/tumorgen-126524 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.